BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 203464)

  • 1. Congenital generalized lipodystrophy with insulin-resistant diabetes.
    Kodama S; Kasuga M; Seki A; Ninomiya M; Sakurai T; Morishita Y; Matsuo M; Matsuo T
    Eur J Pediatr; 1978 Jan; 127(2):111-9. PubMed ID: 203464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in a child with Acanthosis nigricans type A.
    Mariani S; Pedone A; Meschi F; di Natale B; Caputo R; Broggi U; Chiumello G
    Acta Paediatr Scand; 1982 Jul; 71(4):667-70. PubMed ID: 7136687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin resistance with acanthosis nigricans: a case report].
    Fukushima N; Nohara Y; Fujita H; Endo M; Abe K; Matsuura N; Kosaka S; Satomi S
    Nihon Naibunpi Gakkai Zasshi; 1982 Jun; 58(6):807-16. PubMed ID: 6749565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy.
    Oseid S; Beck-Nielsen H; Pedersen O; Sovik O
    N Engl J Med; 1977 Feb; 296(5):245-8. PubMed ID: 831106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and acanthosis nigricans. Report of a case with antibodies to insulin receptors.
    Pulini M; Raff SB; Chase R; Gordon EE
    Ann Intern Med; 1976 Dec; 85(6):749-51. PubMed ID: 1087135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin requirements in lipodystrophic diabetes.
    Mora PF; Ramirez LC; Lender D; Raskin P
    Diabet Med; 1993 Nov; 10(9):863-5. PubMed ID: 8281734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of insulin resistance associated with acanthosis nigricans.
    Fukushima N; Matsuura N; Nohara Y; Fujita H; Endo M; Abe K; Kosaka S; Satomi S
    Tohoku J Exp Med; 1984 Oct; 144(2):129-38. PubMed ID: 6393448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital generalized lipodystrophy in a 4-month-old infant.
    Lee IH; Chen HL; Jeng YM; Cheng MT; Tsao LY; Chang MH
    J Formos Med Assoc; 2001 Sep; 100(9):623-7. PubMed ID: 11695279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial insulin resistance and acanthosis nigricans.
    Praptono R; Sunartini ; Djunduah ; Sadjimin T
    Paediatr Indones; 1990; 30(7-8):213-21. PubMed ID: 2075024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipodystrophy of limbs associated with insulin resistance.
    Lillystone D; West RJ
    Arch Dis Child; 1975 Sep; 50(9):737-9. PubMed ID: 1190824
    [No Abstract]   [Full Text] [Related]  

  • 11. A possible role of circulating lipoprotein-triglycerides in the increase in concentration of free fatty acids and in insulin resistance in "total" lipodystrophy.
    Naito C; Togawa K
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1030-7. PubMed ID: 4430703
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoatrophic diabetes.
    Sasaki T; Ono H; Nakajima H; Sugimoto J
    J Dermatol; 1992 Apr; 19(4):246-9. PubMed ID: 1607489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
    Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
    Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital generalized lipodystrophy and experimental lipoatrophic diabetes in rabbits treated successfully with fenfluramine.
    Trygstad O; Foss I
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):436-48. PubMed ID: 577333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy.
    Park JY; Chong AY; Cochran EK; Kleiner DE; Haller MJ; Schatz DA; Gorden P
    J Clin Endocrinol Metab; 2008 Jan; 93(1):26-31. PubMed ID: 17940115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acanthosis nigricans and congenital total lipodystrophy. Associated anomalies observed in two siblings.
    Brubaker MM; Levan NE; Collipp PJ
    Arch Dermatol; 1965 Apr; 91(4):320-5. PubMed ID: 9626078
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin resistant diabetes showing anti-insulin receptor autoantibody with systemic scleroderma, acanthosis nigricans and total lipodystrophy (author's transl)].
    Sugawara H; Toyota T; Okuguchi F; Umezu M; Kai Y; Abe R; Maruhama Y; Goto Y; Hanew K; Utsumi N
    Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):361-9. PubMed ID: 7381285
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U; Müller R; Berger W
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice.
    Ahrén B; Simonsson E; Scheurink AJ; Mulder H; Myrsén U; Sundler F
    Metabolism; 1997 Jan; 46(1):97-106. PubMed ID: 9005977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
    Wilson DE; Chan IF; Stevenson KB; Horton SC; Schipke C
    J Clin Endocrinol Metab; 1983 Sep; 57(3):517-23. PubMed ID: 6348062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.